Pharma IQ | 06/14/2010
Ensuring eCTD readiness is now critical for gaining first time market approval. Dr. Klaus Menges from the Division of Strategy and Planning, at the Federal Institute for Drugs and Medical Devices, Bfarm joins Pharma IQ to discuss strategies for successful eCTD lifecycle management.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More